ENDRA Life Sciences, Inc. (NDRAU)
NCM · Common · CUSIP 29273B104
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for NDRAU and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
29273B104
Market Cap
Micro Cap · $18 Million
IPO
4/20/2017 · $5.00/unit
Business: ENDRA Life Sciences, Inc. is developing technology designed to increase the capabilities of clinical diagnostic ultrasound to broaden patient access to the safe diagnosis and treatment of a number of significant medical conditions in circumstances where expensive Xray computed tomography, or CT, and magnetic resonance imaging, or MRI, technology is unavailable or impractical.

Company Contact

CEO
Francois Michelon
CFO
David Wells
Headquarters
3600 Green Court, Suite 350, Ann Arbor, MI 48105-1570
Phone
734-335-0468
Investor Relations
Leigh Salvo · 415-937-5403 · investors@endrainc.com
General Email
info@endrainc.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »